Mirador Capital Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
FFM
Mirador Capital Partners's AMGN Position: Q2 2026 in Review
Mirador Capital Partners increased its Amgen (AMGN) stake by 11% in Q2 2026, buying an estimated $49K and bringing the position to 1,410 shares worth $511K. The position accounts for 0.06% of the portfolio, ranked #155.
Mirador Capital Partners first reported a position in AMGN in Q4 2022 and has held it in 15 quarters since. The position peaked at $590K in Q1 2024. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Mirador Capital Partners held 1,410 shares of Amgen worth $511K as of Q2 2026.
- Mirador Capital Partners bought 143 Amgen shares in Q2 2026, an estimated $49K.
- Amgen made up 0.06% of Mirador Capital Partners's portfolio in Q2 2026, its #155 holding.
- Mirador Capital Partners first reported a position in Amgen in Q4 2022 and has held it in 15 quarters since.
- Mirador Capital Partners's Amgen position peaked at $590K in Q1 2024.
- 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Mirador Capital Partners's 13F filing for Q2 2026, filed 7 Jul 2026.